Search
Logo placeholder

Injective Labs Inc.

Office

Headquarters

New York United States

About us

Trailblazing the new dawn of decentralized finance

Injective Labs builds Web3 infrastructure and decentralized finance solutions as a core contributor to Injective, one of the fastest growing blockchains in the industry. The platform provides an interoperable smart contracts environment optimized for financial applications, natively integrated with Ethereum, Cosmos, and Solana. Developers can rapidly launch premier financial applications using Injective's infrastructure and specialized DeFi primitives like the world's first fully on-chain order book. The team spans 51-200 professionals distributed globally, all working to democratize access to financial markets and create a more inclusive financial system through decentralization.

Products

The flagship product is Injective, a sector-specific blockchain built for finance with plug-and-play financial modules and native cross-chain connectivity. Helix serves as the decentralized orderbook crypto exchange for trading spot assets and derivatives with zero gas fees and interchain markets. Mito combines automated strategy vaults for passive yield generation with a one-click token launchpad. The company also operates enterprise-grade validator nodes to secure Web3 projects and has developed Injective Agents, a platform for deploying autonomous AI trading agents with persistent on-chain identities.

Funding

Injective Labs has raised approximately $190 million across multiple rounds since being incubated by Binance Labs in 2018. The company secured $40 million in August 2022 led by Jump Crypto and Brevan Howard Digital. In January 2023, Injective launched a $150 million ecosystem initiative backed by Kraken Ventures, Pantera Capital, KuCoin Ventures, and Delphi Labs. Other notable investors include Mark Cuban, Hashed, and CMS Holdings. By 2025, the platform reached nearly $57 billion in cumulative trading volume with reported revenue of $15.4 million.

Recent news

In July 2025, Canary Capital officially filed a proposal to launch a Staked Injective ETF, marking a major milestone for institutional investment in the ecosystem.

Technology

Front-end development centers on Vue.js 3 with Nuxt.js for server-side rendering and Tailwind CSS for styling. JavaScript, HTML5, and CSS3 form the foundation alongside TypeScript for type safety. REST and gRPC APIs handle backend communication. The blockchain stack leverages Cosmos SDK architecture with CosmWasm and EVM environments for interoperable smart contracts. Proprietary @injectivelabs SDKs facilitate blockchain interaction, while the platform integrates with Ethereum, Solana, and Cosmos ecosystems for cross-chain functionality.

Benefits

Remote-friendly work environment with flexible hours and unlimited PTO. Competitive salary plus INJ token awards let employees share in company success. Equipment and home office stipends support productive remote workspaces. Global team meetups foster collaboration across the distributed team. Health, dental, and vision coverage plus 401(k) with employer match round out the package. The culture emphasizes high ownership, professional growth through mentorship and development roadmaps, plus education and fitness budgets.

Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Frequently asked questions

Find us: